Cited by 241Metabolism, Diabetes, and CancerCancer, Lipids, and MetabolismGrowth Hormone and Insulin-like Growth Factors

The DOI matches its Crossref record; 199 of the 201 references it cites were found in a registry or an index.

Hyperinsulinaemia in cancer

Gallagher, Emily J., LeRoith, Derek·2020·Nature Reviews Cancer

DOI 10.1038/s41568-020-0295-5

Open this paper in CoChat — free account

Abstract

Elevated circulating insulin levels are frequently observed in the setting of obesity and early type 2 diabetes, as a result of insensitivity of metabolic tissues to the effects of insulin. Higher levels of circulating insulin have been associated with increased cancer risk and progression in epidemiology studies. Elevated circulating insulin is believed to be a major factor linking obesity, diabetes and cancer. With the development of targeted cancer therapies, insulin signalling has emerged as a mechanism of therapeutic resistance. Although metabolic tissues become insensitive to insulin in the setting of obesity, a number of mechanisms allow cancer cells to maintain their ability to respond to insulin. Significant progress has been made in the past decade in understanding the insulin receptor and its signalling pathways in cancer, and a number of lessons have been learnt from therapeutic failures. These discoveries have led to numerous clinical trials that have aimed to reduce the levels of circulating insulin and to abrogate insulin signalling in cancer cells. With the rising prevalence of obesity and diabetes worldwide, and the realization that hyperinsulinaemia may contribute to therapeutic failures, it is essential to understand how insulin and insulin receptor signalling promote cancer progression.

Integrity signals

Registry

Crossref · 10.1038/s41568-020-0295-5

Cites

199 of 199 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 retracted

Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment
Pearson‐Stuttard, J., Zhou, B., Kontis, V., Bentham, J., Gunter, M. J., & Ezzati, M. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30150-5 · Cited by 308
Retracted
Retracted: Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment
Pearson‐Stuttard, J., Zhou, B., Kontis, V., Bentham, J., Gunter, M. J., & Ezzati, M. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30366-2 · Cited by 272
Retracted
Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non–Small-Cell Lung Cancer
Karp, D. D., Paz-Ares, L. G., Novello, S., Haluska, P., Garland, L. L., Cardenal, F., Blakely, L. J., Eisenberg, P. D., Langer, C. J., Blumenschein, G. R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9331 · Cited by 260
Retracted
Overexpression of the Insulin Receptor Isoform A Promotes Endometrial Carcinoma Cell Growth
Wang, C., Zhang, G., Zhao, L., Qi, W., Li, X., Wang, J., & Wei, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069001 · Cited by 55
Retracted
Retraction
(2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.3447 · Cited by 10
Retracted
Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114
Body Fatness and Cancer — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596
The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice
Turnbaugh, P. J., Ridaura, V. K., Faith, J. J., Rey, F. E., Knight, R., & Gordon, J. I. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000322 · Cited by 3,058

Show all 201 references

Research works printed but not linked: 1

Agency, E. M. Assessment Report — Steglaro, Vol. 2020 (EMA, 2018).

Sorted by citations

Items 201–241 of 241

Body Mass Index and Metabolic Phenotypes in Breast Cancer Risk: A Meta-Analysis and Systematic Review
Vera-Ponce, V. J., Loayza-Castro, J. A., Vásquez-Romero, L. E. M., & Zuzunaga-Montoya, F. E. (2024) · International Journal of Statistics in Medical Research · doi:10.6000/1929-6029.2024.13.09
Changes in Signal Transmission Between the Nervous System and Peripheral Tissues Influence the Initiation and Progression of Cancer
Mravec, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-68590-3_7
Effect of Diabetes on Outcomes in Patients With Incurable/Unresectable and Advanced/Recurrent Colorectal Cancer Receiving mFOLFOX6
Ikemura, M., Hirabatake, M., Aburaya, M., Ikesue, H., Yasui, H., Muroi, N., & Hashida, T. (2025) · Cancer Diagnosis & Prognosis · doi:10.21873/cdp.10410
Obesity as an etiological and prognostic factor in gastrointestinal cancer
Bielak, K., & Kamińska, K. (2025) · Environmental Medicine · doi:10.26444/ms/199719
Monitoring based on Risk Assessment Effects on Lung Cancer in Iran
Keramatinia, A., Mohseni, M., Monfared, E. D., Ghadyani, R., Rezaei–Tavirani, M., Mozafari, J. K., Masjedi, M. R., & Movafagh, A. (2025) · Current Cancer Therapy Reviews · doi:10.2174/0115733947343796250109051943
Prevalence of cervicovaginal human papillomavirus and cytological abnormalities in immunocompromised women at a tertiary level setting in coastal Karnataka
Pai, P., Guruvare, S., & Saravu, K. (2025) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2025.05.012
Severe Insulin Resistance: Diagnosis and Management
Wu, Y., Wang, X., Zhang, W., Feng, D., & Luo, X. (2025) · Current Diabetes Reviews · doi:10.2174/0115733998390048250902113845
Typ-2-Diabetes mellitus und gastrointestinale Krebsvorsorge
Scherübl, H. (2025) · Diabetologie und Stoffwechsel · doi:10.1055/a-2725-1405
Additional file 4 of Effects of hyperinsulinemia on pancreatic cancer development and the immune microenvironment revealed through single-cell transcriptomics
Zhang, A. M. Y., Chu, K., Daly, B. F., Ruiter, T. J. J., Dou, Y., Yang, J. C. C., de Winter, T. J. J., Chhuor, J., Wang, S., Flibotte, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19211348
Additional file 5 of Effects of hyperinsulinemia on pancreatic cancer development and the immune microenvironment revealed through single-cell transcriptomics
Zhang, A. M. Y., Chu, K., Daly, B. F., Ruiter, T. J. J., Dou, Y., Yang, J. C. C., de Winter, T. J. J., Chhuor, J., Wang, S., Flibotte, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19211351
Additional file 1 of Effects of hyperinsulinemia on pancreatic cancer development and the immune microenvironment revealed through single-cell transcriptomics
Zhang, A. M. Y., Chu, K., Daly, B. F., Ruiter, T. J. J., Dou, Y., Yang, J. C. C., de Winter, T. J. J., Chhuor, J., Wang, S., Flibotte, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19211336
Additional file 1 of Metabolic disorders sensitise endometrial carcinoma through endoplasmic reticulum stress
Zhou, J., Lin, Y., Yang, X., Shen, B., Hao, J., Wang, J., & Wang, J. (2023) · Figshare · doi:10.6084/m9.figshare.22616188
Additional file 3 of Effects of hyperinsulinemia on pancreatic cancer development and the immune microenvironment revealed through single-cell transcriptomics
Zhang, A. M. Y., Chu, K., Daly, B. F., Ruiter, T. J. J., Dou, Y., Yang, J. C. C., de Winter, T. J. J., Chhuor, J., Wang, S., Flibotte, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19211345
Impact of pre-therapeutic fasting plasma glucose on survival outcomes in advanced non-small cell lung cancer patients
Liu, F., Luo, M., Wang, F., Liang, T., & Wang, X. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1630503
Dysregulated autophagy at the nexus of type 2 diabetes mellitus and pancreatic cancer pathogenesis
Li, L., Chen, Y., Wang, S., Du, W., Lao, T., Chen, F., Yao, G., Chen, W., Li, X., Liu, C., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1735726
Integrated tumor tissue metabolomic and transcriptomic approaches for identifying diagnostic biomarkers in endometrial cancer with diabetes mellitusPreprint
Zhang, W., Liu, X., Fu, M., Chen, S., Tian, J., Liu, Y., & Qu, P. (2026) · Research Square · doi:10.21203/rs.3.rs-8035766/v1
Infection trajectories and dementia risk in type 2 diabetes
Xie, P., Lu, Z., Xue, S., Miao, M., Fu, S., Wang, J., Yang, Y., Chen, W., Wu, S., Zhang, J., et al. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02091-6
Evexomostat (SDX-7320), a methionine aminopeptidase type 2 inhibitor, stimulates weight loss and inhibits obesity-accelerated tumor growth
Cornelius, P. K., Mayes, B. A., Dannenberg, A. J., Dufour, P. J., Little, S., Guzior, D. V., Petersen, J. S., Shanahan, J. M., & Carver, B. J. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1751681
Obesity and melanoma: unraveling the paradoxical survival benefit in immunotherapy
Yang, J., Hu, Q., & Xue, C. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-026-10324-3
Atherogenic Lipid Indices in Colorectal Cancer: Metabolic Associations and Survival Outcomes
Marinescu, R. A., Marinescu, D., Boldeanu, L., Ciurea, A.-M., Bică, M., Pătrașcu, Ș., Strâmbu, V., Radu, P. A., Popa, P., Assani, M.-Z., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16050810
The Gut–Adipose–Tumor Axis in Obesity-Related Cancer
Feng, J., Huang, Y., Lai, S., Zhao, T., Xie, Y. Q., Zhu, X., Liu, L., Tang, D., & Yan, A. (2026) · Nutrients · doi:10.3390/nu18081230
Global, regional, and national analyses of the burden of pancreatic cancer attributable to high fasting plasma glucose from 1990 to 2021: A longitudinal observational study
Han, J., Liang, Q., Lv, Y., Chen, H., Lei, X., Liao, C., Yang, S., & Chu, F. (2026) · Medicine · doi:10.1097/md.0000000000048315
Diabetes as a determinant of neurosurgical vulnerability: Rethinking perioperative risk in meningioma resection
Karmakar, R., Kaushik, A., Gade, P., Gawali, M., & Mukundan, A. (2026) · World Journal of Diabetes · doi:10.4239/wjd.119009
Breast Cancer and Metabolic Dysfunction-Associated Steatotic Liver Disease
Nieva-Ramírez, D. G., Luna-Pérez, D., Uribe, M., & Nuño‐Lámbarri, N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114919
Molecular interplay of insulin resistance and cancer: advances in monoclonal antibody therapeutics
Moni, S. S., Ayish, F., Musawi, S., Salawi, A., Elmobark, M. E., Jabeen, A., Mohammed, M. A. A., Aqdi, M. J., Aziabi, M. Y., Harbi, R. H., et al. (2026) · Cancer Biology & Therapy · doi:10.1080/15384047.2026.2708386
Cardiovascular-kidney-metabolic health, genetic susceptibility, and incident cancer risk: a prospective UK biobank cohort and machine learning study
He, X., An, J., Yan, C., Zhou, Y., Wu, Z., Xu, M., & He, Q. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1884752
Adverse cardio-metabolic risk profile and epicardial adiposity in patients with adrenal adenoma: a cross-sectional study
Niziolek, H., Just, I., Tosin, A., Baumgartner, C., Koldyka, O., Körmöczi, K., Fellinger, P., Beiglböck, H., Bellach, L., Domenig, O., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1898271
Heterogeneous associations of antidiabetic medications with cancer prognosis: Evidence from 61 studies with over 1.1 million patients
Luo, P., Ding, Y., Huang, W., Ma, W., Lan, X., Zhang, J., Yang, X., & Lin, A. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108420
Postdiagnosis healthy dietary patterns in relation to all-cause and cause-specific mortality and life expectancy among adults with type 2 diabetes: evidence from cohort studies
Qiu, Z., Liu, G., Liu, B., Hu, Y., Wang, P., Zhang, Y., Wang, S., AlEssa, H. B., Rimm, E. B., Wang, M., et al. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101510
Comparative Analysis of Phytochemical Compounds, Antioxidant, and Anti-Inflammatory Activity of Different Plant Parts of Lansium domesticum Corr.
Evary, Y. M., Lallo, S., Habibie, H., Amir, M. N., & Laela, D. (2026) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v10i8.29
Breast Cancer and Diabetes Mellitus: Epidemiology, Pathophysiology, and Clinical Outcomes
Saeed, H., Habib, R., Arnold, E., Ahmed, S., & Shahid, R. K. (2026) · American Journal of Medicine Open · doi:10.1016/j.ajmo.2026.100143
Chronic hepatitis C and metabolic dysfunction-associated steatotic liver disease: converging pathobiology, hepatocarcinogenesis, and clinical implications in the post-SVR era
El‐Kassas, M., Awad, A., AlNaamani, K. M., Alswat, K., & Elzouki, A.-N. (2026) · Hepatoma Research · doi:10.20517/2394-5079.2026.57
Immunometabolic interactions in gynecologic cancers: Mechanisms, biomarkers, and therapeutic implications
Chuwa, A. H., & Mvunta, D. H. (2026) · Journal of International Medical Research · doi:10.1177/03000605261476189
Comprehensive assessment of the genotype-phenotype spectrum and treatment for monoallelic insulin receptoropathy in a cohort of 505 peoplePreprint
Brown, R., Xu, J., Luan, J., Donadille, B., Aslanzadeh, V., Bellanné‐Chantelot, C., Grasso, V., Collin‐Chavagnac, D., Mucciolo, M., Allix, I., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10884175/v1
Ketosis Suppression and Ageing (KetoSAge) Trial: Effect of Hypoketonaemia on Extracellular Vesicle Profiles in Healthy Premenopausal Women
Cooper, I. D., Petagine, L., Cooper, N., Soto-Mota, A., Edwards, K., Kraev, I., Lange, S., & Kyriakidou, Y. (2026) · Clinical bioenergetics · doi:10.3390/clinbioenerg2040016
Construction of a Prognostic Model for Pancreatic Cancer Based on mitochondrial dynamics-Related Genes: Application of Multiple Machine Learning MethodsPreprint
Gongping, M., Liu, Y., & Shu, Q. (2026) · Research Square · doi:10.21203/rs.3.rs-10614363/v1
Insulin mimetics and non-canonical insulin receptor signaling: mechanisms and disease relevance
Park, J., & Choi, E. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01862-5
The gut-pancreas axis: microbial dysbiosis as a pathogenic driver of diabetes and pancreatic cancer
Li, Y. (2026) · Medical Oncology · doi:10.1007/s12032-026-03421-4
Metabolic oncology: clonal selection and the pre-existing origins of cancer resistance
Perez, C. A., & Khaled, A. R. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1951576
Diabetes and Cancer-Pathophysiology and Clinical Implications: A Systematic Review
Hasan, Z., Moni, Z. A., Kamal, T., Hossain, M. M., Kabir, Y., & Islam, F. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48101086
Theoretical Considerations Regarding the Role of Hyperinsulinemia and Insulin/IGF Signaling in Cancer Metabolic Reprogramming: Potential Mechanisms and Therapeutic Vulnerabilities
Chae, B. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219598

Authors: Gallagher, E. J., & LeRoith, D.
Affiliations: Tisch Cancer Institute (US)
Corresponding author: Gallagher, Emily J.
ORCID: Gallagher, Emily J.
LeRoith, Derek
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2020-09-09
Volume: 20
Issue: 11
Pages: 629-644
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/s41568-020-0295-5
OpenAlex: W3084040947
Cited by: 241
References: 201
Citations by year: 2026: 48 · 2025: 41 · 2024: 37 · 2023: 39 · 2022: 41 · 2021: 34 · 2020: 1
FWCI: 2.78
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (K08CA190770)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords: hyperinsulinemia, insulin receptor signaling, insulin resistance, obesity, type 2 diabetes, tumor progression, cancer therapy resistance, insulin receptor, tumor growth
MeSH terms: Diabetes Mellitus, Type 2, Humans, Hyperinsulinism, Insulin, Insulin Resistance, Neoplasms, Obesity, Receptor, Insulin, Signal Transduction, Antigens, CD, Comorbidity, Drug Resistance, Neoplasm

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hyperinsulinaemia in cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks